Back
Illumina 10K Form
Sell
42
ILMN
Illumina
Last Price:
208.96
Seasonality Move:
4.15%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-02-17 | 10K | ILMN/Illumina Annual |
| 2020-10-30 | 10Q | ILMN/Illumina Quarterly |
| 2020-08-07 | 10Q | ILMN/Illumina Quarterly |
| 2020-05-01 | 10Q | ILMN/Illumina Quarterly |
| 2020-02-11 | 10K | ILMN/Illumina Annual |
| 2019-10-25 | 10Q | ILMN/Illumina Quarterly |
Receive ILMN News And Ratings
See the #1 stock for the next 7 days that we like better than ILMN
ILMN Financial Statistics
Sales & Book Value
| Annual Sales: | $4.58B |
|---|---|
| Cash Flow: | $-43M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $42.36 |
| Price / Book: | 4.9 |
Profitability
| EPS (TTM): | -28.53000 |
|---|---|
| Net Income (TTM): | $-4.49B |
| Gross Margin: | $2.97B |
| Return on Equity: | -54.24% |
| Return on Assets: | -33.97% |
Illumina Earnings Forecast
Key Illumina Financial Ratios
- The Gross Profit Margin over the past 24 years for ILMN is 64.83%.
- The Selling, General & Administrative Expenses for ILMN have been equal to 28.29% of Gross Profit Margin.
- The Research & Development expenses have been 28.82% of Revenue.
- The Interest Expense is -0.59% of Operating Income.
- The Net Earning history of ILMN is -96.07% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 15 years.
Illumina Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | S&P500 |
|---|---|
| Industry: | Diagnostics & Research |
| Sector: | Healthcare |
| Current Symbol: | ILMN |
| CUSIP: | 452327 |
| Website: | illumina.com |
Debt
| Debt-to-Equity Ratio: | 0.33 |
|---|---|
| Current Ratio: | 1.42 |
| Quick Ratio: | 0.98 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 64.34 |